PP
PCRX icon

Paloma Partners’s Pacira BioSciences PCRX Stock Holding History

Paloma Partners’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,151
Closed -$209K – 1418
2024
Q1 		$209K Buy
+7,151
New +$220K 0.01% 597
2020
Q4 		– Sell
-4,512
Closed -$271K – 2092
2020
Q3 		$271K Buy
4,512
+324
+8% +$18.8K 0.01% 1554
2020
Q2 		$220K Buy
+4,188
New +$175K ﹤0.01% 1639
2019
Q2 		– Sell
-5,752
Closed -$219K – 2080
2019
Q1 		$219K Buy
+5,752
New +$224K 0.01% 1470
2018
Q1 		– Sell
-9,903
Closed -$452K – 2195
2017
Q4 		$452K Buy
+9,903
New +$392K 0.01% 1371
2017
Q1 		– Sell
-8,023
Closed -$259K – 2170
2016
Q4 		$259K Buy
+8,023
New +$268K ﹤0.01% 1751
2016
Q3 		– Sell
-13,944
Closed -$470K – 2056
2016
Q2 		$470K Buy
+13,944
New +$685K 0.01% 1563

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return